New Zealand markets closed

Novartis AG (NVS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
94.36+1.79 (+1.93%)
At close: 04:00PM EDT
94.50 +0.14 (+0.15%)
After hours: 05:05PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 191.59B
Enterprise value 203.97B
Trailing P/E 23.01
Forward P/E 13.35
PEG ratio (5-yr expected) 5.14
Price/sales (ttm)4.23
Price/book (mrq)4.13
Enterprise value/revenue 4.37
Enterprise value/EBITDA 11.17

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 3-6.19%
S&P500 52-week change 320.07%
52-week high 3108.78
52-week low 392.19
50-day moving average 398.20
200-day moving average 399.75

Share statistics

Avg vol (3-month) 31.51M
Avg vol (10-day) 31.7M
Shares outstanding 52.04B
Implied shares outstanding 62.05B
Float 81.96B
% held by insiders 10.00%
% held by institutions 16.92%
Shares short (28 Mar 2024) 44.21M
Short ratio (28 Mar 2024) 42.77
Short % of float (28 Mar 2024) 4N/A
Short % of shares outstanding (28 Mar 2024) 40.21%
Shares short (prior month 29 Feb 2024) 44.53M

Dividends & splits

Forward annual dividend rate 43.78
Forward annual dividend yield 44.00%
Trailing annual dividend rate 33.92
Trailing annual dividend yield 34.23%
5-year average dividend yield 43.58
Payout ratio 485.33%
Dividend date 319 Apr 2024
Ex-dividend date 407 Mar 2024
Last split factor 21116:1000
Last split date 309 Apr 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 31.83%
Operating margin (ttm)25.37%

Management effectiveness

Return on assets (ttm)7.27%
Return on equity (ttm)16.15%

Income statement

Revenue (ttm)46.66B
Revenue per share (ttm)22.47
Quarterly revenue growth (yoy)7.40%
Gross profit (ttm)N/A
EBITDA 17.52B
Net income avi to common (ttm)8.57B
Diluted EPS (ttm)4.10
Quarterly earnings growth (yoy)478.40%

Balance sheet

Total cash (mrq)14.07B
Total cash per share (mrq)6.89
Total debt (mrq)26.44B
Total debt/equity (mrq)56.55%
Current ratio (mrq)1.15
Book value per share (mrq)22.83

Cash flow statement

Operating cash flow (ttm)14.46B
Levered free cash flow (ttm)12.13B